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Abstract: Squash smear cytology of Langerhans cell histiocytosis (LCH) has rarely been reported. We described 
squash cytological findings of cranial LCH. Additionally, based on recent data that suggests an association of LCH 
with either viral infection or genetic alteration, we investigated the presence of several viruses or mutation of TP53 
and BRAF in LCH tissue samples. Intraoperative squash smears of a small tissue fragment excised from the lesion 
demonstrated a mixed population of eosinophils, neutrophils, small lymphocytes and a high content of histiocytes. 
The histiocytes possessed abundant dense cytoplasm with round cell shape and eccentrically located nuclei with 
fine chromatin, delicate nuclear membranes and prominent nuclear grooves, indentations and pseudoinclusions. 
The cytologic features were consistent with Langerhans cells (LCs). Subsequent histopathologic examination con-
firmed the diagnosis of LCH. Immunohistochemically, the LCs were positive for S-100, CD1a and langerin, but nega-
tive for adenovirus, CMV, EBV, HHV-8, HPV, HSV, SV 40 and p53. BRAF V600E mutation was absent. Our findings did 
not support the role of viruses and genetic abnormalities in the pathogenesis of LCH. In summary, the presence of 
a mixed population of inflammatory cells and a high content of histiocytes with characteristic cytomorphology, along 
with radiologic evidence and appropriate clinical findings, is highly suggestive of LCH on the intraoperative squash 
smears. Awareness of characteristic cytological features of LCH is necessary for rapid and accurate diagnosis. 
Squash smear cytology is a potentially useful tool in the intraoperative diagnosis of LCH.
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Introduction
Langerhans cell histiocytosis (LCH) is a rare dis-
ease that accounts for less than 1% of all 
tumor-like lesions of bone mainly affecting the 
skull, femur, mandible and ribs [1]. In the past, 
the disease was referred to as histiocytosis X 
with 3 variants: eosinophilic granuloma, Hand-
Schuller-Christian disease and Letterer-Siwe 
syndrome that represent different expressions 
of the same disease, now known as LCH [2]. 
There is a wide spectrum of clinical manifesta-
tions of LCH that depends on the location and 
extent of the proliferation of Langerhans cell 
(LCs). LC is a major type of nonlymphoid mono-
nuclear cell involved in both inflammatory 
responses and neoplastic processes. There is 
an ongoing debate on whether the pathogene-
sis of LCH includes a reactive or neoplastic pro-
cess. Inflammatory reaction to viral infection is 
reportedly the potential etiology at disease 
onset [3-7]. However, no convincing evidence 
has emerged for an infectious cause of LCH. 
There are several reports on immune dysregula-
tion and aberrant cytokine expression in 
patients with LCH, indicating that the nature of 
LCH is predominantly immune or inflammatory 
[8-10]. However, the role of cytokines and 
immune system regulators in the pathogenesis 
of LCH remains controversial. Meanwhile, the 
discovery of frequently recurring oncogenic 
BRAF mutations in LCH, along with TP53 muta-
tion, supports the classification of this disease 
as a neoplasm [11]. However, there is also a 
debate about the source of pathologic LCs in 
LCH lesions. Furthermore, the presence of BRA 
For TP53 mutation alone may not be sufficient 
for tumorigenesis. Even though the identifica-
tion of genetic alterations in LCH strongly sup-
ports the hypothesis of its neoplastic nature, 
several questions remain unanswered.
Squash smear cytology is of great value in intra-
operative pathologic consultations. It provides 
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a rapid and reliable intraoperative diagnosis 
and guidance to the surgeon during surgical 
resection and lesion targeting. It also helps the 
surgeon to monitor and modify the surgical 
approach. Using a very small amount of mate-
rial, this technique makes it possible to detect 
cellular details and establish a provisional 
pathologic diagnosis [12]. In published series 
and case reports of LCH, its diagnosis has been 
established using routine histopathologic 
methods [4, 12-14]; the morphology of LCH is 
well recognized in processed biopsy or excised 
material. In contrast, the squash cytology 
description of LCH is limited. Knowledge of its 
cytomorphology, nevertheless, is of diagnostic 
importance [12, 15-17]. The appearance on 
squash smears has certain characteristic and 
diagnostic features. We described squash 
smear cytological findings for rapid and correct 
intraoperative diagnosis of cranial LCH in chil-
dren. The findings of this study will increase the 
accuracy of the pathologists’ cytological diag-
nosis and guide appropriate management. 
Additionally, we investigated a possible rela-
tionship between LCH and viral infection or 
TP53 and BRAF mutation. The presence and 
cellular localization of viruses, as well as p53 
expression status, was examined using immu-
nohistochemical staining and in situ hybridiza-
tion. The presence of BRAF V600E mutation 
was also examined using polymerase chain 
reaction (PCR).
Case presentation
Case 1
A 12-year-old boy presented to the neurosur-
gery outpatient department with a painless 
swelling of the frontal part of the head of 6 
weeks duration. The lesion was not accompa-
nied by fever or tenderness. There was no his-
Figure 1. Imaging findings of LCH. Case 1: (A) A plain skull roentgenogram revealed a punched-out osteolytic lesion 
in the mid-portion of frontal bone (white arrow). (B) A sagittal view of T1-weighted TFE MR image showed a well-
demarcated enhancing lesion (white arrow), which abuts the meninges. (C) An axial view of T2-weighted TSE MR im-
age revealed that the mass (white arrow) involved the inner table of skull bone. Case 2: A plain skull roentgenogram 
(D, anteroposterior view; E, lateral view) revealed a well-demarcated osteolytic lesion in the left frontal bone (white 
arrow). (F) CT scan showed a localized osteolysis (white arrow), involving the inner and outer tables.
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tory of trauma, headache or vomiting. Local 
examination revealed a firm and slightly mobile 
swelling of approximately 1.5 cm in diameter 
over the upper forehead. The overlying skin 
appeared normal. Systemic examination was 
otherwise unremarkable, and the patient was 
neurologically normal. He had no lymphade-
nopathy, organomegaly, skin rash or any other 
abnormality. Complete routine laboratory tests 
including hematological and biochemical inves-
tigations revealed no abnormality. A plain skull 
roentgenogram revealed a sharply demarcat-
ed, punched-out osteolytic lesion in the most 
anterior midline point on the frontal bone, 
approximately 3 centimeters above the glabella 
(Figure 1A). Sagittal (Figure 1B) and axial 
(Figure 1C) view of magnetic resonance imag-
ing (MRI) scan demonstrated an osteolytic 
lesion in the frontal bone. Surgical excision with 
intraoperative frozen section and squash cyto-
logical preparations was performed. Subse- 
quent permanent section diagnosis, followed 
by immunohistochemical staining, Epstein-Barr 
virus (EBV)-encoded RNA in situ hybridization 
(EBER-ISH) and analysis for BRAF V600E muta-
tion detection, was also performed. The prima-
ry cytological diagnosis of LCH was made using 
squash preparations, and confirmed by the fro-
zen and permanent sections. The postopera-
tive course was uneventful, and the patient left 
the hospital 5 days later. Fourteen months 
after surgery, MRI scan showed no evidence of 
recurrence. Whole body positron emission 
tomographic scan showed no abnormal hyper-
metabolic lesion.
Case 2
A 6-year-old girl was referred to our hospital 
presenting with painful swelling over the left 
side of forehead for a month. There was no his-
tory of trauma, headache or vomiting. On exam-
ination, a fluctuant, ill-defined soft tissue mass 
of approximately 2 cm in diameter was identi-
fied on the left frontal region. The underlying 
bone appeared to be indented on palpation, 
and the overlying skin appeared normal. She 
had no significant past medical history. 
Lymphadenopathy or skin rash was not found. 
The liver and spleen were not palpable. Other 
physical examination and laboratory tests were 
unremarkable. A plain skull roentgenogram 
(Figure 1D, anteroposterior view; Figure 1E, lat-
eral view) revealed a well-demarcated osteo-
lytic lesion in the left frontal bone. Computed 
tomographic (CT) scan also showed a localized 
osteolysis of the frontal bone with erosion of 
the inner and outer tables, along with suspect-
ed involvement of the adjacent soft tissue 
(Figure 1F). As in Case 1, surgery with intraop-
erative frozen section and squash smears was 
performed. The primary cytological diagnosis of 
LCH was further confirmed by the tissue sec-
tions. The ancillary tests, including immunohis-
tochemistry, EBER-ISH and BRAF V600E muta-
tional analysis, were performed. The postoper-
ative course was uneventful, and the patient 
left the hospital 4 days later. No recurrence 
over the last 6 months was apparent.
Materials and methods
Squash cytological preparation
For squash cytology, biopsy samples obtained 
at the time of surgery were transported imme-
diately in small vials containing isotonic saline 
for processing in the pathology departments’ 
cryolaboratory. One to 2 millimeters of the biop-
Table 1. Antibodies used for immunohistochemical staining
Antibody Source Clone Dilution
Adenovirus Millipore Corporation, Bedford, MA, USA 20/11 & 2/6 1:500
CD1a DakoCytomation, Glostrup, Denmark 10 1:50
CD3 DakoCytomation, Glostrup, Denmark Polyclonal 1:200
CD20 Novocastra Laboratories, Newcastle upon Tyne, UK L26 1:400
CMV DakoCytomation, Glostrup, Denmark CCH2/DDG9 1:40
HHV-8 Novocastra Laboratories, Newcastle upon Tyne, UK 13B10 1:50
HPV DakoCytomation, Glostrup, Denmark K1H8 1:100
HSV Novocastra Laboratories, Newcastle upon Tyne, UK 20.7.1 1:3,000
p53 Invitrogen, Carlsbad, CA, USA BP53.12 1:5,000
S-100 DakoCytomation, Glostrup, Denmark Polyclonal 1:5,000
SV 40 Calbiochem, Merck KGaA, Darmstadt, Germany PAb416 1:100
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sy material were crushed between 2 glass 
slides with just enough pressure to spread the 
tissue into a thin film; the smear was subse-
quently fixed in 95% alcohol and stained by 
hematoxylin and eosin. The residual tissue 
sample was stored at -20°C or fixed in 10% for-
malin solution and embedded in the paraffin 
block. Formalin-fixed, paraffin-embedded sec-
tions were stained with hematoxylin and eosin 
for light microscopy.
Immunohistochemistry
Immunohistochemical staining was performed 
by using standard reagents and techniques, as 
previously described [18-24]. Briefly, the sec-
tions were deparaffinized with Bond Dewax 
solution (Leica Biosystems, Bannockburn, IL, 
USA) and an antigen retrieval procedure was 
performed using Bond Epitope Retrieval solu-
tion 1 (Leica Biosystems) for 30 min at 100°C. 
Endogenous peroxidases were blocked by incu-
bation with hydrogen peroxide for 5 min and the 
sections were incubated for 15 min at ambient 
temperature with primary antibodies (Table 1). 
Staining was performed using a biotin-free 
polymeric horseradish peroxidase-linker anti-
body conjugate system with a Leica Bond-Max 
automated immunostainer (Leica Microsys- 
tems), and the slides were visualized with 3, 
3’-diaminobenzidine (DAB) solution (1 mm DAB, 
50 mm Tris-HCl buffer [pH 7.6] and 0.006% 
H2O2). In addition, the nuclei were counter-
stained with hematoxylin, and the slides were 
dehydrated through a series of graded alcohols 
(70%, 90% and 100%), cleared in xylene 
(Sigma-Aldrich, St. Louis, MO, USA) and sealed 
Figure 2. Squash cytological findings of LCH. A. LCs displayed centrally or eccentrically located, oval or retiform, 
grooved or contorted nuclei (black arrows), and were admixed with inflammatory background. B. They had abun-
dant, dense cytoplasm and round or oval cell shape. Their nuclei possessed fine granular chromatin and delicate 
nuclear membranes and intranuclear cytoplasmic pseudoinclusion (blue circle). C. A prominent folded configuration 
manifested as nuclear grooves (yellow circle) and pseudoinclusions (blue circle). D. An eccentrically located nucleus 
showed a large pseudoinclusion (blue circle). E. The background consisted predominantly of numerous eosinophils 
with bilobed nuclei (white arrows). F. Some neutrophils, scattered small lymphocytes and multinucleated giant cells 
were accompanied. 
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with coverslips. Positive and negative controls 
were done according to manufacturer’s 
instruction.
EBV-encoded RNA in situ hybridization and 
CD3/CD20 double staining
The formalin-fixed, paraffin-embedded sec-
tions obtained from excised specimens were 
used for EBER-ISH and CD3 or CD20 double 
staining. The sections of LCH tissue were depa-
raffinized with xylene (Sigma-Aldrich), pretreat-
ed with proteinase K for 20 min and incubated 
with fluorescein isothiocyanate (FITC)-conju- 
gated EBER oligonucleotide probes (Novocastra 
Laboratories, Newcastle upon Tyne, UK) at 
55°C for 2 h. The sections were rinsed in water 
and incubated with horseradish peroxidase-
conjugated anti-FITC antibody for 15 min before 
adding fresh 3, 3-DAB color substrate to pro-
duce an alcohol-insoluble brown intranuclear 
stain in EBV-positive cells. Immediately follow-
ing the EBER-ISH, immunohistochemical stain-
ing with CD3 and CD20 was performed on the 
Leica Bond-maX autostainer (Leica Micro sys-
tems) using standard reagents and techniques 
to produce fast red membranous stain in either 
CD3- or CD20-positive cells. We used EBV-
negative lymphoid tissues processed using the 
hybridization mixture without EBER oligonucle-
otides as negative controls.
Detection of BRAF V600E mutation
For the detection of BRAF V600E mutation, 
nucleic acids from fresh tissue were isolated 
using a DNA extraction kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s pro-
tocol. Briefly, isolated nucleic acids were mixed 
with a PCR master mix from a Seeplex- 
BRAF V600E ACE detection kit (Seegene Inc., 
Seoul, Republic of Korea). The mixed samples 
were immediately placed in a preheated (94°C) 
thermal cycler for 15 min, and PCR was carried 
Figure 3. Histological (A-C) and immunohistochemical (D-F) findings of LCH. (A) At low power, diffuse infiltration of 
LCs was noted. (B) LCs were admixed with eosinophils, neutrophils, lymphocytes and multinucleated giant cells (C) 
Consistent with squash cytological findings, characteristic nuclear indentations (yellow circles) and grooves were 
detected. Immunohistochemically, the LCs were strongly reactive for (D) CD1a, (E) S-100 and (F) langerin.
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out using the recommended program in a 
GeneAmp PCR 9700 system (Applied 
Biosystems, Foster City, CA, USA). The cycling 
amplification program consisted of 35 cycles: 
denaturation for 30 s at 94°C, annealing for 30 
s at 63°C and extension for 1 min at 72°C. The 
amplified PCR products were loaded onto a 2% 
agarose gel and visualized with Safe View Stain 
(Applied Biological Materials Inc., Richmond, 
BC, Canada). The BRAF V600E mutation was 
detected with a Gel Documentation system 
(Bio-Rad Laboratories Inc., Hercules, CA, USA).
Results
Smears were highly cellular and showed numer-
ous histiocytes as the predominant cell type 
scattered singly or in loosely cohesive clusters 
with an admixture of a polymorphic population 
of inflammatory cells (Figure 2A). The histio-
cytes were large cells with abundant, dense 
cytoplasm and round or oval cell shape (Figure 
2B). Their nuclei, eccentrically or centrally 
located, had characteristic features, consisting 
of fine granular chromatin, delicate nuclear 
membranes and a distinctive, prominent folded 
configuration manifested as nuclear grooves 
(with a coffee bean appearance; Figure 2C), 
indentations and pseudoinclusions (Figure 2D). 
The nucleoli were inconspicuous to small, but 
occasionally, were prominent. Mitotic figures 
were rare. The cytological features of these his-
tiocytes were consistent with LCs. The back-
ground of the smears consisted of numerous 
eosinophils with bilobed nuclei (Figure 2E), 
neutrophils, scattered small lymphocytes, plas-
ma cells and multinucleated giant cells (Figure 
2F). Cytological diagnosis of LCH was made.
Macroscopically, the specimen revealed a gray-
white, soft mass that involved the skull bone. 
Microscopically, a diffuse infiltrate of LCs 
Figure 4. Findings of immunohistochemical staining for viruses (A-F and I) and EBER-ISH (G and H). LCs did not 
demonstrate immunoreactivity for (A) adenovirus, (B) CMV, (C) HHV-8, (D) HPV, (E) HSV and (F) SV 40. Double stain-
ing for EBER-ISH and CD3 or CD20 showed that neither LCs, (G) CD3-positive T-lymphocytes nor (H) CD20-positive 
B-lymphocytes exhibited EBV positivity. (I) LCs displayed scattered, weak to moderate nuclear p53 immunoreactivity, 
indicating wild-type expression pattern (absence of TP53 mutation).
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(Figure 3A) was admixed with eosinophils, poly-
morphonuclear leukocytes, lymphocytes and 
multinucleated giant cells (Figure 3B). The LCs 
were large-sized and polygonal, with abundant 
glassy eosinophilic cytoplasm. Round to oval, 
grooved nuclei displayed finely granular or 
slightly vesicular chromatin (Figure 3C). 
Multinucleation was evident. Mitotic figures 
were rarely seen. No necrosis was detected. 
Immunohistochemically, the LCs were strongly 
reactive for CD1a (Figure 3D), S-100 (Figure 
3E) and langerin (Figure 3F), confirming the 
diagnosis of LCH.
Based on the recent data that suggests that 
viral infection is associated with the pathophys-
iology of LCH [3-6, 25], we further investigated 
whether viruses were present in the LCH 
lesions. However, LCs did not demonstrate 
immunoreactivity for any of the following anti-
bodies: adenovirus (Figure 4A), cytomegalovi-
rus (CMV; Figure 4B), human herpesvirus-8 
(HHV-8; Figure 4C), human papilloma virus 
(HPV; Figure 4D), herpes simplex virus (HSV; 
Figure 4E) and simian virus 40 (SV 40; Figure 
4F). We also performed double staining for 
EBER-ISH and CD3/CD20 to investigate wheth-
er EBV infects bystander T- or B-lymphocytes. 
However, neither LCs, T-lymphocytes (Figure 
4G) nor B-lymphocytes (Figure 4H) exhibited 
EBV positivity.
We assessed the status of 2 known molecular 
abnormalities in LCH, i.e., p53 protein expres-
sion and the presence of BRAF V600E muta-
tion in order to find evidence of neoplastic 
pathogenesis [11, 26]. However, no mutant 
pattern of p53 expression was observed in LCs 
(Figure 4I). No LCH tissue samples exhibited 
BRAF V600E mutation.
Discussion
The diagnosis of LCH in our patients was made 
on the basis of characteristic cytomorphology 
on squash cytological preparations. This was 
corroborated by appropriate radiological and 
clinical findings. In the present cases, both MRI 
and CT scans showed lytic lesions in the skull 
bones with sharp borders and punched-out 
appearances. In Case 2, destruction of both 
inner and outer tables resulted in a double-con-
tour or a beveled-edge appearance, which is a 
typical roentgenographic finding in the diagno-
sis of LCH [4, 27].
This report highlights the usefulness of squash 
cytological preparations for rapid intraopera-
tive diagnosis. Intraoperative frozen section is 
an important component of surgical manage-
ment of tumors. Critical decision regarding 
treatment and the extent of surgical resection 
can sometimes depend on an appropriate 
intraoperative cytological diagnosis [28]. The 
cytological findings were similar to those 
described in fine needle aspiration samples of 
LCH in other organs [29-34]. In the present 
cases, the squash smears displayed a high cel-
lularity consisting of isolated or loosely aggre-
gated LCs with eccentrically located, oval to 
reniform nuclei showing delicate nuclear mem-
branes and prominent nuclear grooves, inden-
tations and pseudoinclusions. These were 
admixed with a polymorphic population of 
inflammatory cells with a predominance of 
eosinophils. The key to the diagnosis is identifi-
cation of LCs through characteristic nuclear 
features, i.e., nuclear grooves and pseudoinclu-
sions. However, occasionally, the LCs are few or 
nuclear grooves not very prominent. Further- 
more, they can show variable degree of pleo-
morphism and mitotic activity [31, 32, 35, 36]. 
Similarly, the degree of eosinophilic infiltration 
varies in different areas of the LCH lesion, thus 
their number can vary from scant to abundant 
in cytology smears [35]. Nevertheless, the 
presence of eosinophils can help attract atten-
tion to the diagnosis of LCH. There have been 
several case reports on the cytologic features 
of LCH, but most of these cases were taken 
from the bone or thyroid as aspiration cytology 
[2, 29-34]. There is only one previous Japanese 
case demonstrating squash cytologic features 
of LCH of the skull [12]. Together with previous 
reports, we demonstrated that squash cyto-
morphology closely reflects histomorphology.
The cytological diagnosis may be missed due to 
lack of familiarity with its cytomorphology 
among pathologists or due to the lack of char-
acteristic cytological findings resulting from a 
sampling error. Therefore it is prudent for the 
pathologist to consider this diagnosis only in an 
appropriate clinical and radiological setting. It 
is also necessary to be familiar with cytological 
features of other differential diagnoses. The 
most common differential diagnoses of cranial 
LCH include Ewing sarcoma, non-Hodgkin lym-
phoma and osteomyelitis with abundant histio-
cytes. Ewing sarcoma and non-Hodgkin lym-
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phoma are characterized by a monomorphic 
population of small round blue cells. In acute 
osteomyelitis, numerous neutrophils forma 
prominent component of inflammatory lesion. 
The observed reactive histiocytes can be easily 
distinguished due to the absence of character-
istic features of LCs. Plasma cells and lympho-
cytes predominate in chronic osteomyeltis. 
Neutrophils and plasma cells can be present, 
but infrequent in LCH.
A possible relationship between the develop-
ment of LCH and expression of some human 
herpes viruses has been reported [25]. The 
granulomatous nature of LCH lesions and the 
generally benign morphology of pathologic LCs 
have suggested possible infectious, environ-
mental or autoimmune pathogeneses [3, 5]. In 
particular, EBV infects monocytes and LCs and 
is associated with the pathophysiology of LCH 
according to some studies [3, 5-7, 25]. However, 
other studies failed to replicate these findings, 
and the possible causative role of EBV in LCH is 
debated [37-39]. Shimakage and colleagues 
[25] showed positive signals for EBER-ISH in 17 
cases of LCH, in contrast, McClain and col-
leagues [37] failed to find evidence of genomes 
for EBV in 56 LCHs. Slacmeulder and col-
leagues [40] demonstrated the absence of 
HHV-8 DNA in 12 LCH biopsy specimens. 
Similarly, herpes viruses such as EBV, CMV and 
HHV-6 have been detected in clinical samples 
[41], but differences in the overall prevalence 
or titers of antibodies against these viruses 
were not significant between LCH patients and 
controls. Consistent with earlier reports that 
were unable to document an association 
between herpes viruses and LCH, we did not 
observe immunoreactivity for all viruses exam-
ined [37-40, 42]. Double staining for EBER-ISH 
and CD3 or CD20 revealed the absence of EBV 
in B- and T-lymphocytes. However, we could not 
definitively exclude an association of EBV infec-
tion with LCH because of a number of EBV-
infected cells infiltrating LCH lesion, suggestive 
of an EBV-infected B-lymphocytes and LC inter-
action that might contribute to the develop-
ment of LCH [40, 41]. Jeziorski and colleagues 
[41] observed that EBV-positive cells were 
labeled with CD20 or CD79a, but not with 
CD1a, CD3 or CD68, indicating that EBV infects 
bystander B-lymphocytes and not LCs. Thus, 
EBV-infected B-lymphocytes in the lesion may 
trigger the activation of LCs and eventually the 
development of LCH in some cases.
We did not observe the mutation pattern (either 
diffuse and strong positivity or complete 
absence of immunoreactivity) of p53 protein 
expression. BRAF V600E mutation was absent. 
Some previous studies have shown TP53 muta-
tion and p53 overexpression in LCH [11, 43], 
raising the possibility that p53 may be a prima-
ry contributor to a hyperproliferative, trans-
formed phenotype through its inability to induce 
apoptosis [26]. Furthermore, the demonstra-
tion of BRAF V600E mutation in more than a 
half of LCH samples examined provides the 
recurrent genomic abnormality that is required, 
in addition to clonality, to assign LCH a neoplas-
tic origin [11]. However, p53 overexpression 
can be a normal secondary response to a prolif-
erative stimulus. There are several examples of 
benign, reactive proliferative disorders that are 
characterized by high levels of p53 expression 
[44-46]. Likewise, BRAF mutation alone may 
be necessary but not sufficient for the develop-
ment of LCH; several additional genetic abnor-
malities are required for tumorigenesis. Much 
effort is required to identify additional genetic 
abnormalities in LCH and to understand the 
molecular basis of its pathogenesis.
In conclusion, the presence of a mixed popula-
tion of inflammatory cells, including abundant 
eosinophils, and a high content of histiocytes 
with characteristic cytomorphology on the 
intraoperative squash smears, along with radio-
logic evidence and appropriate clinical findings, 
is highly suggestive of LCH. Nuclear features 
including grooves and pseudoinclusions were 
evident in squash cytological smears, closely 
reflecting histomorphology of LCH. Squash 
smear cytology can serve as a useful tool for 
the intraoperative diagnosis of LCH. Awareness 
of cytological features of LCH, its differential 
diagnoses and causes of diagnostic pitfall is 
necessary. In addition, our results did not sup-
port an association between LCH and viral 
infection or genetic abnormalities. Although the 
precise etiology remains to be elucidated, our 
understanding of LCH has been greatly 
enhanced by the application of advanced 
genomic technologies to the analysis of primary 
human material. Further investigation is 
required to clarify the molecular pathogenesis 
of LCH.
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